Who owns CYCLACEL PHARMACEUTICALS INC?
- Ticker: CYCC
- CUSIP Number: 23254l801
Tip: Access positions for across all investors
Analyze quarterly positions in Cyclacel Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cyclacel Pharmaceuticals stock
Who bought or sold CYCLACEL PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 581k | $218k | 300% | Dec 2024 |
|
| UBS Group | 47k | $24k | 277% | Dec 2024 |
|
| Two Sigma Securities | 29k | $11k | 100% | Dec 2024 |
|
| Point72 Asset Management | 15k | $5.8k | 0% | Dec 2024 |
|
| Acadian Asset Management | 14k | $5.0k | 0% | Dec 2024 |
|
| Geode Capital Management | 11k | $4.1k | 2% | Dec 2024 |
|
| Tower Research Capital | 5.6k | $2.1k | 39% | Dec 2024 |
|
| SBI Securities | 802.00 | $302.033200 | 100% | Dec 2024 |
|
| Financial Gravity Companies | 200.00 | $75.000000 | 100% | Dec 2024 |
|
| Archer Investment Corp | 200.00 | $75.000000 | 100% | Dec 2024 |
|
| Activest Wealth Management | 133.00 | $49.994700 | 0% | Dec 2024 |
|
| Advisor Group Holdings | 126.00 | $123.996600 | 0% | Dec 2024 |
|
| Morgan Stanley | 80.00 | $30.000000 | 0% | Dec 2024 |
|
| Bank of America Corporation | 51.00 | $18.997500 | 240% | Dec 2024 |
|
| Wells Fargo & Company | 33.00 | $11.998800 | 0% | Dec 2024 |
|
| Signature | 20.00 | $8.000000 | 0% | Dec 2024 |
|
| Harbour Investments | 13.00 | $4.999800 | 0% | Dec 2024 |
|
Who sold out of Cyclacel Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| McIlrath & Eck | Sep 2024 | 166.00 | $164.008000 |